[Thalidomide induced peripheral neuropathy in multiple myeloma patients].

Abstract

INTRODUCTION Thalidomide, a sedative popular in the 1950s and withdrawn from the market in the 1960s because of its teratogenic effects, has emerged again on the market in the last decade as an effective agent in the treatment of multiple myeloma. Unfortunately, apart from positive treatment effects, numerous side effects have been shown in multiple myeloma… (More)

Topics

Cite this paper

@article{Banach2015ThalidomideIP, title={[Thalidomide induced peripheral neuropathy in multiple myeloma patients].}, author={Marta Banach and Artur Jurczyszyn and Aleksander Skot{\~n}icki}, journal={Przeglad lekarski}, year={2015}, volume={72 11}, pages={629-35} }